Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography.
Zhao ChenGuang LiaoNa WanZhiyou HeDaji ChenZhichao TangZhe LongGuangdong ZouLinliu PengLinlin WanChunrong WangHuirong PengYuting ShiYongxiang TangJian LiYulai LiTingting LongXuan HouLang HeRong QiuDengming ChenJun-Ling WangJi-Feng GuoLu ShenYiyun HuangTetsuo AshizawaThomas KlockgetherBei-Sha TangMing ZhouShuo HuJiang HongPublished in: Movement disorders : official journal of the Movement Disorder Society (2023)
We first identified in vivo synaptic loss was related to disease severity of SCA3, suggesting SV2A PET could be a promising clinical biomarker for disease progression of SCA3. © 2023 International Parkinson and Movement Disorder Society.